Apriso: Medgend

Search instead for prison

Apriso FDA Approved Drugs

APRISO [Mesalamine^{C₇H₇NO₃}]

375mg (oral capsule, extended release)

Valeant Pharms Intl^{Oct 31, 2008}

For the maintenance of remission of ulcerative colitis in subjects 18 years of age and older.
For the maintenance of remission of ulcerative colitis.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ASACOL HD [Mesalamine^{C₇H₇NO₃}]

800mg (oral tablet, delayed release)

Apil^{May 29, 2008}

Treatment of ulcerative colitis.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CANASA [Mesalamine^{C₇H₇NO₃}]

1gm (rectal suppository)

Forest Labs Llc^{Nov 5, 2004}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

DELZICOL [Mesalamine^{C₇H₇NO₃}]

400mg (oral capsule, delayed release)

Apil^{Feb 1, 2013}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

LIALDA [Mesalamine^{C₇H₇NO₃}]

1.2gm (oral tablet, delayed release)

Shire^{Jan 16, 2007}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

MESALAMINE [Mesalamine^{C₇H₇NO₃}]

1.2gm (oral tablet, delayed release)

1gm (rectal suppository)

4gm/60ml (rectal enema)

Zydus Pharms Usa Inc^{Jun 5, 2017}
Mylan Pharms Inc^{Nov 24, 2015}
G And W Labs Inc^{Sep 30, 2004}
Perrigo Israel^{Sep 17, 2004}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

PENTASA [Mesalamine^{C₇H₇NO₃}]

250mg (oral capsule, extended release)

500mg (oral capsule, extended release)

Shire^{May 10, 1993}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ROWASA [Mesalamine^{C₇H₇NO₃}]

4gm/60ml (rectal enema)

Mylan Speciality Lp^{Dec 24, 1987}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

SFROWASA [Mesalamine^{C₇H₇NO₃}]

4gm/60ml (rectal enema)

Mylan Speciality Lp^{Jun 20, 2008}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER [Conivaptan Hydrochloride^{C₃₂H₂₆N₄O₂ClH}]

20mg/100ml (0.2mg/ml) (iv (infusion) injectable)

Cumberland Pharms^{Oct 8, 2008}

Method of using antagonist of arginine vasopressin (ava) v1a and v2 receptors for intravenous treatment of patients with euvolemic hyponatremia.
Method of using antagonist of arginine vasopressin (ava) v1a and v2 receptors for intravenous treatment of patients with hypervolemic hyponatremia.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Apriso FDA Approved Drugs